Skip to main content
. 2020 Aug 3;15(8):e0236411. doi: 10.1371/journal.pone.0236411

Fig 1. Availability of the investigated medicines in public health facilities, faith-based health facilities, and private pharmacies.

Fig 1

a) Availability of generic medicines. b) Availability of originator brands. c) Overall availability of the medicines (generic or originator). * Medicines allowed at hospital level only.